NCT06081881View on ClinicalTrials.gov

Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions
Chronic Thromboembolic Pulmonary Hypertension
All Listed Sponsors
lead

Ester Ashraf Faried Beshay

OTHER

NCT06081881 - Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism | Biotech Hunter | Biotech Hunter